CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-14 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −20,967 | $25.92 | $543K | 17,011,202 |
| 2023-06-14 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −36,281 | $26.24 | $952K | 16,974,921 |
| 2023-06-13 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −36,547 | $26.81 | $980K | 17,102,476 |
| 2023-06-13 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −70,307 | $27.23 | $1.9M | 17,032,169 |
| 2023-06-07 | Pang Phillip Chief Medical Officer | Option exercise 10b5-1 | +5,000 | $1.53 | $8K | 193,000 |
| 2023-06-07 | Pang Phillip Chief Medical Officer | Sale 10b5-1 | −5,000 | $25.95 | $130K | 188,000 |
| 2023-06-07 | Pang Phillip Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 47,591 | ||
| 2023-06-05 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −5,197 | $27.32 | $142K | 17,139,023 |
| 2023-06-02 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −34,365 | $27.32 | $939K | 17,144,220 |
| 2023-06-01 | Rice Steven J. Chief Administrative Officer | Sale 10b5-1 | −2,500 | $25.67 | $64K | 106,840 |
| 2023-06-01 | Ramasastry Saira Director | Sale 10b5-1 | −3,500 | $25.67 | $90K | 10,619 |
| 2023-05-24 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −35,307 | $25.89 | $914K | 17,247,662 |
| 2023-05-24 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −66,754 | $26.25 | $1.8M | 17,180,908 |
| 2023-05-24 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −2,323 | $27.12 | $63K | 17,178,585 |
| 2023-05-23 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −2,317 | $25.84 | $60K | 17,450,719 |
| 2023-05-23 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −144,402 | $26.61 | $3.8M | 17,306,317 |
| 2023-05-23 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −23,348 | $27.02 | $631K | 17,282,969 |
| 2023-05-22 | NELSEN ROBERT Director | Grant or award | +6,027 | 576,148 | ||
| 2023-05-22 | NELSEN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +12,054 | 12,054 | ||
| 2023-05-22 | PEREZ ROBERT J Director | Grant or award | +6,027 | 15,806 |
Page 12 of 54 · 1,063 trades